Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02656680 · ClinicalTrials.gov registry record · NA
Facebook and Friends: Developing an Effective Online Social Network for Weight Loss
A NA study of Weight Loss, sponsored by University of Connecticut.
- Completed
- Registry status
- NA
- Development phase
- 134
- Enrollment target
- 1
- Study location
NCT02656680: Completed NA study of Weight Loss, sponsored by University of Connecticut.
NCT02656680 is a NA study of Weight Loss that has completed, run by University of Connecticut. The registered enrollment target is 134 participants, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02656680, a NA study of Weight Loss, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- NA
- Development phase
- 134 participants
- Enrollment target
- 1
- Study location
Study Summary
In a pilot randomized trial of 160 obese participants, investigators will test the feasibility of a behavioral weight loss program delivered entirely via Facebook. We will recruit in 2 separate waves of 80 participants each. Participants will be randomized to: 1) a condition with study participants only or 2) to a condition they will be able to invite their friends into (wave 1) or one in which the study team keeps recruitment open to allow enrollment through week 8 (wave 2). All participants will receive behavioral counseling via the private Facebook group from the coaches who are present on the network daily. Participants will track their diet and exercise via a free commercial mobile app.
Primary Outcome
Number of Facebook "likes" and other reactions, replies, posts, and polls per participant during the 16 week program.
Conditions Studied
Interventions
- BEHAVIORAL Continuous Enrollment
- BEHAVIORAL Closed Enrollment
Study Locations (1)
Connecticut
- University of Connecticut - Storrs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2020-03-31 |
| Phase | NA |
What the finished NCT02656680 record still lists
NCT02656680 is an interventional study that assigns participants to a tested intervention. The registered 134 participants enrollment target is mid-sized for trials with a published cap, below the 1,500-participant average among 116 other Weight Loss trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which Continuous Enrollment is the first listed.
NCT02656680 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT02656680 about?
NCT02656680 is a clinical study titled "Facebook and Friends: Developing an Effective Online Social Network for Weight Loss". In a pilot randomized trial of 160 obese participants, investigators will test the feasibility of a behavioral weight loss program delivered entirely via Facebook. We will recruit in 2 separate waves of 80 participants each. Participants will be randomized to: 1) a condition with study participants ...
What is the current status of trial NCT02656680?
This trial is currently completed. It is a NA study. The enrollment target is 134 participants. The study started on 2018-02-01. Estimated completion is 2020-03-31.
What conditions does trial NCT02656680 study?
This clinical trial studies the following conditions: Weight Loss.
What interventions are being tested in trial NCT02656680?
The interventions under investigation include: Continuous Enrollment (BEHAVIORAL), Closed Enrollment (BEHAVIORAL).
Who is sponsoring clinical trial NCT02656680?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02656680 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02656680's enrollment target sits among peer trials
134 37th of 116 higher than 80 of 116 other Weight Loss trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Weight Loss trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02469662 · 134 participants · NA
Clinical Outcomes Study of the Nexel Total Elbow
- NCT03110822 · 134 participants · Phase 1
A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
- NCT04678648 · 134 participants · Phase 1
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
- NCT05264857 · 134 participants · NA
Decision Aid and Thyroid Nodules Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI